BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34594326)

  • 1. NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
    Pontarini E; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Fossati-Jimack L; Coleby R; Chowdhury F; Calcaterra F; Tappuni A; Lewis MJ; Fabris M; Quartuccio L; Bella SD; Bowman S; Pitzalis C; Mavilio D; De Vita S; Bombardieri M
    Front Immunol; 2021; 12():706737. PubMed ID: 34594326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.
    Rusakiewicz S; Nocturne G; Lazure T; Semeraro M; Flament C; Caillat-Zucman S; Sène D; Delahaye N; Vivier E; Chaba K; Poirier-Colame V; Nordmark G; Eloranta ML; Eriksson P; Theander E; Forsblad-d'Elia H; Omdal R; Wahren-Herlenius M; Jonsson R; Rönnblom L; Nititham J; Taylor KE; Lessard CJ; Sivils KL; Gottenberg JE; Criswell LA; Miceli-Richard C; Zitvogel L; Mariette X
    Sci Transl Med; 2013 Jul; 5(195):195ra96. PubMed ID: 23884468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
    Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot JM; Chiche L; Hachulla E; Hatron PY; Goeb V; Vittecoq O; Saraux A; Pers JO
    J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse model.
    Jin JO; Shinohara Y; Yu Q
    PLoS One; 2013; 8(10):e77605. PubMed ID: 24147035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome.
    Verstappen GM; Gao L; Pringle S; Haacke EA; van der Vegt B; Liefers SC; Patel V; Hu Y; Mukherjee S; Carman J; Menard LC; Spijkervet FKL; Vissink A; Bootsma H; Kroese FGM
    Front Immunol; 2021; 12():681941. PubMed ID: 34295332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
    Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
    Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
    Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
    Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
    Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
    Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
    Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbed natural killer cell homeostasis in the salivary gland enhances autoimmune pathology
    Sato M; Arakaki R; Tawara H; Nagao R; Tanaka H; Tamura K; Kawahito Y; Otsuka K; Ushio A; Tsunematsu T; Ishimaru N
    Front Med (Lausanne); 2022; 9():1036787. PubMed ID: 36388880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
    Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
    Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.
    Li N; Li L; Wu M; Li Y; Yang J; Wu Y; Xu H; Luo D; Gao Y; Fei X; Jiang L
    Front Immunol; 2021; 12():697157. PubMed ID: 34367157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome.
    Ciccia F; Giardina A; Rizzo A; Guggino G; Cipriani P; Carubbi F; Giacomelli R; Triolo G
    Ann Rheum Dis; 2013 May; 72(5):782-3. PubMed ID: 23264342
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
    Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
    Lisi S; Sisto M; D'Amore M; Lofrumento DD
    Int Immunol; 2015 Apr; 27(4):183-94. PubMed ID: 25381666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.
    Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE
    J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation.
    Rivière E; Pascaud J; Tchitchek N; Boudaoud S; Paoletti A; Ly B; Dupré A; Chen H; Thai A; Allaire N; Jagla B; Mingueneau M; Nocturne G; Mariette X
    Ann Rheum Dis; 2020 Nov; 79(11):1468-1477. PubMed ID: 32843324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.